# Bloodworks – FDA Inspection, Feb 15, 2013

Source: https://www.keypedia.com/records/fda_inspections/bloodworks/52e601cf-08cf-4082-99b8-165cd825e531
Source feed: FDA_Inspections

> FDA inspection 819984 of Bloodworks, February 15, 2013. Classification: Official Action Indicated (OAI). 15 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 819984
- Company Name: Bloodworks
- Inspection Date: 2013-02-15
- Classification: Official Action Indicated (OAI)
- Classification Code: OAI
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 0

## Related Documents

- [FDA Inspection 1294906 - 2025-12-11](https://www.keypedia.com/records/fda_inspections/bloodworks/434763ad-6025-46be-a3e0-aafe9ee382fa)
- [FDA Inspection 1238690 - 2024-05-03](https://www.keypedia.com/records/fda_inspections/bloodworks/c6717275-d4f5-4c45-adc7-b32b8f50196e)
- FDA Inspection 1146276 - 2021-07-16
- [FDA Inspection 1087821 - 2019-04-18](https://www.keypedia.com/records/fda_inspections/bloodworks/ce14ee5e-146d-405d-9e6e-6b2051446a29)
- FDA Inspection 1056331 - 2018-06-07

Company: https://www.keypedia.com/companies/bloodworks/7ecb0a9c-b4a3-41bb-8c61-3be1042e3e8e

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d